Washington—The U.S. Food and Drug Administration will convene a dental advisory panel Dec. 14-15 to discuss “whether FDA appropriately represented the strengths and weaknesses of the available clinical data” in issuing 2009 dental amalgam regulations.
-
Recent Posts
Contact Us!
Blogroll
Tags